Health Care & Life Sciences » Pharmaceuticals | Consun Pharmaceutical Group Ltd.

Consun Pharmaceutical Group Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,155
1,368
585
751
1,188
1,448
Total Accounts Receivable
298
305
461
632
1,184
1,008
Inventories
63
67
85
157
240
240
Other Current Assets
12
6
15
11
11
36
Total Current Assets
1,528
1,746
1,146
1,551
2,623
2,732
Net Property, Plant & Equipment
297
287
267
438
497
646
Total Investments and Advances
3
3
763
24
25
20
Intangible Assets
-
-
-
904
937
857
Other Assets
32
30
103
141
165
149
Total Assets
1,866
2,079
2,289
3,078
4,288
4,444
ST Debt & Current Portion LT Debt
-
-
-
-
232
Accounts Payable
26
46
47
89
83
Income Tax Payable
14
34
33
69
114
Other Current Liabilities
152
143
193
452
735
Total Current Liabilities
192
223
274
610
1,165
Long-Term Debt
-
-
-
-
450
Deferred Taxes
45
37
38
124
129
Other Liabilities
-
-
-
-
25
Total Liabilities
243
272
322
755
1,810
Common Equity (Total)
1,610
1,791
1,953
1,964
2,097
Total Shareholders' Equity
1,610
1,791
1,953
1,964
2,097
Total Equity
1,610
1,791
1,953
2,299
2,478
Liabilities & Shareholders' Equity
1,866
2,079
2,289
3,078
4,288
Accumulated Minority Interest
-
-
-
335
381
Non-Equity Reserves
12
15
14
24
-

About Consun Pharmaceutical Group

View Profile
Address
71 Dong Peng Avenue, Eastern Section
Guangzhou Guangdong 510760
China
Employees -
Website http://www.chinaconsun.com
Updated 07/08/2019
Consun Pharmaceutical Group Ltd. is an investment holding company, which engages in the manufacturing and sales of pharmaceutical products. It operates through Consun Pharmaceutical and Yulin Pharmaceutical segments. The Consun Pharmaceutical segment manufactures and sells modern Chinese medicines and medical contrast medium.